Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA-topoisomerase I complex is a transient, covalent intermediate formed during the catalytic cycle of the topoisomerase I (TOP1) enzyme. TOP1 is a critical nuclear enzyme that relieves torsional strain in DNA by creating reversible single-strand breaks, allowing the DNA to rotate and relax during replication and transcription (Pommier, 2006, Nature Reviews Cancer; UniProt P11387). During this process, the enzyme becomes covalently linked to the 3'-phosphate end of the DNA, forming what is known as the Top1-DNA cleavage complex (Top1cc) (Thomas et al., 2004, Chemical Reviews). This complex is the specific molecular target for camptothecin-based drugs and their derivatives, which act as topoisomerase poisons by binding at the enzyme-DNA interface (Pommier, 2013, Nature Reviews Cancer). By stabilizing the Top1cc, these drugs prevent the religation of the DNA strand, effectively trapping the enzyme on the DNA. When advancing replication forks or transcription complexes collide with these trapped Top1cc units, they generate lethal double-strand breaks that trigger apoptosis (Murai et al., 2012, Cell Reports). Clinically, targeting this complex is a cornerstone in the treatment of various malignancies, including colorectal, lung, and ovarian cancers.
Stabilization of the covalent DNA-topoisomerase I cleavage complex (interfacial inhibition), preventing DNA religation and causing replication-mediated double-strand breaks.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-topoisomerase I complex (Top1cc).